Search - tctmd.com

Displaying 61 - 80 of 849

Sort: Relevancy | Date

Presentation TCT 2017

Commentary I Insights From the 3M Trial

Presenter: David A. Wood

November 01, 2017

Presentation TCT 2017

Surgical Treatment of RV Outflow Tract Obstruction: From RV-PA Conduit to TAP

Presenter: Elchanan Bruckheimer, Doff B. McElhinney, Damien J. LaPar

November 01, 2017

Presentation TCT 2017

Device Sizing for the Amplatzer PFO Occluder: Forget the IFU

Presenter: John F. Rhodes, Robert J. Sommer, Richard Smalling

November 01, 2017

Presentation TCT 2017

Counterpoint A Customized Approach, Including General Anesthesia and TEE, Optimizes Patient Outcomes!

Presenter: Omar K. Khalique

November 01, 2017

Presentation TCT 2017

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Presenter: Samir R. Kapadia, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

Point TAVR Without General Anesthesia and Without TEE is now the Default Strategy!

Presenter: Ganesh Manoharan

November 01, 2017

Presentation TCT 2017

Review of PFO Closure Devices, and an Anatomy-specific Approach to Device Selection

Presenter: John F. Rhodes, Robert J. Sommer, Mark Reisman

November 01, 2017

Presentation TCT 2017

Case #1: A Dreaded TAVI Complication

Presenter: Amal Kumar Banerjee, Purvez K Grant, Nagendra Singh Chouhan

November 01, 2017

Presentation TCT 2017

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Presenter: Samir R. Kapadia, Ashish Pershad

November 01, 2017

Presentation TCT 2017

Counterpoint Clinical Trial Results are Inconclusive and Systematic Use of Cerebral Protection During TVR is Unwarranted!

Presenter: Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Tricuspid Valve-in-Valve and Valve-in-Ring

Presenter: Francesco Maisano, Jason H. Rogers, Paul Sorajja

November 01, 2017

Presentation TCT 2017

Point A Balanced Look at ALL the Data Favors Cerebral Protection in ALL TAVR Patients!

Presenter: Saif Anwaruddin

November 01, 2017

Presentation TCT 2017

Transcatheter TR Solution 8: GATE Valve

Presenter: Francesco Maisano, Jason H. Rogers, Jose Luis Navia

November 01, 2017

Presentation TCT 2017

TAVR in Patients With Severe CKD: Diagnostic Workup, Valve Sizing, and Procedural and Post-Procedure Management

Presenter: Nirat Beohar

November 01, 2017

Presentation TCT 2017

Transcatheter TR Solution 7: TRAIPTA

Presenter: Francesco Maisano, Jason H. Rogers, Toby Rogers

November 01, 2017

Presentation TCT 2017

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? No!

Presenter: Lee N. Benson, Megan Coylewright, David E. Thaler

November 01, 2017

Presentation TCT 2017

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

Presenter: Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? Yes!

Presenter: Lee N. Benson, Megan Coylewright, Guillaume Turc

November 01, 2017

Presentation TCT 2017

Transcatheter TR Solution 6: Millipede

Presenter: Francesco Maisano, Jason H. Rogers, Steven F. Bolling

November 01, 2017

Presentation TCT 2017

Transcatheter TR Solution 5: Cardioband

Presenter: Francesco Maisano, Jason H. Rogers, Ralph Stephan von Bardeleben

November 01, 2017

Advertisement

Commentary I Insights From the 3M Trial

Surgical Treatment of RV Outflow Tract Obstruction: From RV-PA Conduit to TAP

Device Sizing for the Amplatzer PFO Occluder: Forget the IFU

Counterpoint A Customized Approach, Including General Anesthesia and TEE, Optimizes Patient Outcomes!

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Point TAVR Without General Anesthesia and Without TEE is now the Default Strategy!

Review of PFO Closure Devices, and an Anatomy-specific Approach to Device Selection

Case #1: A Dreaded TAVI Complication

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Counterpoint Clinical Trial Results are Inconclusive and Systematic Use of Cerebral Protection During TVR is Unwarranted!

Tricuspid Valve-in-Valve and Valve-in-Ring

Point A Balanced Look at ALL the Data Favors Cerebral Protection in ALL TAVR Patients!

Transcatheter TR Solution 8: GATE Valve

TAVR in Patients With Severe CKD: Diagnostic Workup, Valve Sizing, and Procedural and Post-Procedure Management

Transcatheter TR Solution 7: TRAIPTA

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? No!

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? Yes!

Transcatheter TR Solution 6: Millipede

Transcatheter TR Solution 5: Cardioband

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content